Skip to main content

1 Result(s)

within Evgeny Levchenko Remove this filter

and

  1. No Access

    Article

    A phase Ib study of GSK3052230, an FGF ligand trap in combination with pemetrexed and cisplatin in patients with malignant pleural mesothelioma

    Background Fibroblast growth factors (FGFs) have a fundamental role in cancer. Sequestering FGFs with GSK3052230 (FP-1039) blocks their ability to activate FGFRs while avoiding toxicities associated with small mo...

    Emilie M. J. van Brummelen, Evgeny Levchenko, Manuel Dómine… in Investigational New Drugs (2020)